Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) on Wednesday formally introduced a wide-ranging bill to address so-called "surprise" medical bills that would establish a benchmark provider payment rate for out-of-network services, instead of the arbitration process favored by hospital industry groups.

U.S. residents increasingly are visiting Canada to purchase insulin, as costs for the diabetes treatment in the United States have spiked in recent years.

Despite some experts' calls to divert patients away from costly academic medical centers (AMCs), research demonstrates that AMCs might produce better patients outcomes—and might not cost as much as some policymakers fear, a trio of prominent health care experts argue.

CMS Administrator Seema Verma in August 2018 warned HHS Secretary Alex Azar against three policy changes that she estimated would decrease Affordable Care Act exchange enrollment by 1.1 million and jeopardize the exchange market, according to an internal memo.

Liv Cannon's fiancé thought it was a scam when Cannon received an explanation of benefits detailing a nearly $100,000 medical charge about a year after she underwent life-changing back surgery—but it turns out the charge was real.

The Commonwealth Fund on Wednesday released its 2019 Scorecard on State Health System Performance, which ranks all 50 states on key measures of health.

Three pharmaceutical companies and the Association of National Advertisers on Friday filed a lawsuit challenging HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, claiming the final rule exceeds HHS' statutory authority and violates the First Amendment of the Constitution.

The median total costs insurers and patients paid for the 49 most popular prescription drugs in the United States, by sales, increased between 2012 and 2017, with many of those costs increasing more than twofold, according to a recent study.

The Trump administration on Thursday finalized a rule that will allow U.S. workers to use employer-funded health reimbursement arrangements to purchase private health coverage.

CMS on Wednesday approved Washington's plan to negotiate value-based drug agreements with the makers of hepatitis C treatments under a subscription-like model.